Hints and tips:
...The chief executive of Bristol-Myers Squibb described the US government’s support for waiver as “very concerning” during an interview at the FT US Pharma and Biotech Summit on Thursday....
...According to SEC filings, Elon Musk’s company is the $60bn hedge fund’s second largest holding, behind Bristol-Myers Squibb....
...Andy Schmeltz, who heads the division, gives the example of Eliquis, an anticoagulant produced with Bristol-Myers Squibb....
...The healthcare sector saw almost no losses in the session, helped by gains from Bristol-Myers Squibb and Pfizer after the companies said their blood thinner Apixaban (Eliquis) had seen some positive trial...
International Edition